Eris Lifesciences Limited IPO Message Board (Page 29)

Tejas Networks IPO – Issue Information:

Issue Opens on: 16 June 2017
Issue Closes on: 20 June 2017
Issue Type: Book Built Issue IPO
Issue Size: 2,88,75,000 Equity Shares
Face Value: Re.1 per Equity Share
Issue Price: Rs.??? – Rs.??? per Equity Share
Market Lot: ?? Shares
Listing At: NSE, BSE

Equity Shares outstanding prior to the Issue = 13,75,00,000 Equity Shares
Offer for Sale of 2,88,75,000 Equity Shares @upper price band = Rs.??? Crores
Equity Shares outstanding after the Issue = 13,75,00,000 Equity Shares

Category-wise Break up:.
Anchor – 1,29,26,250 Shares = ???Crs
QIB – 86,17,500 Shares = ???Crs
NII – 43,08,750 Shares = ???Crs
RII – 28,72,500 Shares = ???Crs (Lot size: ??? = ??? Forms)
Empl – 1,50,000 Shares = ???Crs

Total Issue – 2,88,75,000 Equity Shares = ???Crs.

as per news paper Price fixed for Tejas Network
253-260

Pardon my error ... Please replace "Tejas Networks" ... with "ERIS LIFESCIENCES"

Tentative Information ...

Eris LifeSciences IPO – Issue Information: (Tentative)

Issue Opens on: 16 June 2017
Issue Closes on: 20 June 2017
Issue Type: Book Built Issue IPO
Issue Size: 2,88,75,000 Equity Shares
Face Value: Re 1 per Equity Share
Issue Price: Rs.575 – Rs.600 per Equity Share (Tentative)
Market Lot: 25 Shares
Listing At: NSE, BSE

Equity Shares outstanding prior to the Issue = 13,75,00,000 Equity Shares
Offer for Sale of 2,88,75,000 Equity Shares @upper price band = Rs.1,732.50 Crores
Equity Shares outstanding after the Issue = 13,75,00,000 Equity Shares

Category-wise Break up:.
Anchor – 1,29,26,250 Shares = 775.58Crs
QIB – 86,17,500 Shares = 517.05Crs
NII – 43,08,750 Shares = 258.53Crs
RII – 28,72,500 Shares = 172.35Crs (Lot size: 25 = 114,900 Forms)
Empl – 1,50,000 Shares = 9.00Crs

Total Issue – 2,88,75,000 Equity Shares = 1732.50Crs.

Subscription required for 1X
RII = 114,900 Forms
NII = 258.53 Crs

Interest cost @6%p.a. for 7days = 69.041paise for 1X

Eris LifeSciences IPO
Market Estimates of oversubscription:

Category-wise:

1X QIB(Net) = 517.05Crs – assuming applications of 12KCrs. = 23X oversubscription

1X NII = 258.53Crs – assuming applications of 35KCrs. = 135X oversubscription

1X RII = 114,900 Forms – assuming 8L forms. = 7X oversubscription (applic-wise)
i.e. average 3.6 shares per form

Eris LifeSciences IPO

GMP 100
Kostak 300 – 350

CARG and growth have been brilliant and the news in market is that it will will aggressively priced Rs.700 i hope the news is not true and it just rumours

market is king let wait for price band however i agree at 700 it is expensive

Piramal had sold their domestic formulation business At 9 times sales which considered to be very good at that time. N Abbott didn''t make any money in this deal .
At 7000Cr Mcap its valuation almost similar to 9 times sales of 750 cr sales of Eris.

@500 absolutely Not cheap at Any valuation matrixes

Eris Lifesciences IPO

Financial Information (Basis of Valuation):

EPS for FY14-15 >>> Rs.6.49 (Page #84 of RHP)
EPS for FY15-16 >>> Rs.9.71 (Page #84 of RHP)
EPS for FY16-17 >>> Rs.17.61 (Page #84 of RHP)

RoNW for FY14-15 >>> 33.59% (Page #85 of RHP)
RoNW for FY15-16 >>> 44.64% (Page #85 of RHP)
RoNW for FY16-17 >>> 44.84% (Page #85 of RHP)

NAV as on March 31, 2017 was Rs.39.85 (Page #85 of RHP)

Peer Group (Page #86 of RHP):
GlaxoSmithKline Pharmaceuticals
Abbott India
Sanofi India
Pfizer

Any price above 500 look expensive given the current status of pharma industry

All big competitors in India for eris is generic only. Only differentiating factor for eris is its demestic focus .

Alkem PAT almost 900 crore this year n Mcap of 22000 cr (70% demostic sales)PE 25

@500 Eris PAT of Rs 240 cr n Mcap will be 7000 cr. PE 29

Eris 39 out of almost 240 brands extensions representing 12% of revenue comes under Price control

at 500 it is expensive

last fourpharma IPO

syngene
alkem
advance enzyme
larus

have given great return so market will take 500

but from what i hear IT COULD BE CLOSE TO Rs 700 which would be not that attractive IPO


IMO it should be more like 400 and not 500 at 500 it looks full price

however as i said before even with 500

it has picked peers all MNC which normally have better PE multiple. IMO they should have picked Pharma company close to 5000 cr MC

Eris LifeSciences IPO – Schedule – Page #290 of RHP

15th June – Anchor List
16h June – Offer Opens
20th June – Offer Closes
23st June – Finalisation of Basis of Allotment
27th June – Unblocking of ASBA
28th June – Credit to Demat Accounts
29th June – Listing on NSE & BSE

IPO to open June 16, close June 20 price band and lot size will be update soon

i have download the RHP will have read and comment soon

BID/OFFER OPENS ON* Friday, June 16, 2017
BID/OFFER CLOSES ON Tuesday, June 20, 2017
FINALIZATION OF BASIS OF ALLOTMENT On or about Friday, June 23, 2017
INITIATION OF REFUNDS FOR ANCHOR INVESTORS/UNBLOCKING OF FUNDS On or about Tuesday, June 27, 2017
CREDIT OF EQUITY SHARES TO DEPOSITORY ACCOUNTS On or about Wednesday, June 28, 2017
COMMENCEMENT OF TRADING Thursday, June 29, 2017

5K Crore IPOs

http://www.livemint.com/Money/44tcD52b4p7V5d87o4NlWJ/IPOs-worth-Rs5000-crore-lined-up-this-month.html

Tejas
CDSL
Eris
Au Small Finance
GTPL Hathway

ERIS IPO
16-20 JUNE
confirm

that means If anyone wish to apply for all the IPOs then one should arrange funds for 3 application per account

Price Band ?

Please bear with common question: Any koshtak and gap info?

REVENUE FROM OPERATION FY16 5970 FY 17 3708 (IN MILLION )

EBITDA FY 16 1715 FY17 1471

PA FY 16 1336 FY 17 1297

OPERATING CASH FLOWS FY16 1315 FY 17 1232

FREE CASH FLOWS FY 16 1078 FY 17 1160

EPS FY 16 9.71 FY 17 9.43

AS per data on site

APPLY OR AVOID ?

F2F 17 data annualised or 9 month data???

BSE SME IPO index

http://www.livemint.com/Money/Wn551NwlHaxIcUKtTCtMFP/BSE-SME-IPO-index-surges-53-outperforms-broader-market.html

It may be possible the issue price come in range of 600-700 and P/E of more than 30 make it expensive issue

1 (Ek rupiya ka) 700 keya sahi lagta hy???????????😢☺😊

1 (Ek rupiye 😢ka) 700 keya sahi lagta hy???????????😢☺😊

Forum modulator, please add for gtpl hathway link also as management declared that it''s IPO is planned for June.

GMP ?